(-)-Syringaresinol 4-O-β-D-glucopyranosi( —— )

Catalog No. M17979 CAS No. 137038-13-2

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

(-)-Syringaresinol 4-O-β-D-glucopyranosi
Note

Research use only, not for human use.
Brief Description

(-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
Description

(-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
In Vitro

Episyringaresinol 4'-O-β-D-glncopyranoside inhibits NO production in LPS-induced N9 microglial cells dramatically in a dose independent manner with an IC50 of 91.50 μM.
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

CAS Number

137038-13-2
Formula Weight

580.58
Molecular Formula

C28H36O13
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (172.24 mM)
SMILES

O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1OC2=C(OC)C=C([C@@H]3OC[C@]4([H])[C@@]3([H])CO[C@H]4C5=CC(OC)=C(O)C(OC)=C5)C=C2OC
Chemical Name

——